Evidence map›Paper›PMID 41959341›Full record

ArticlebioRxiv : the preprint server for biology2026

Cellector: A tool to detect foreign genotype cells in scRNAseq data with applications in leukemia and microchimerism.

Haynes Heaton, Reza Behboudi, Collin Ward, Minindu Weerakoon, Sami Kanaan, Skylar Reichle, Nathan Hunter, Scott Furlan

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Haynes HeatonAuburn University, Auburn, AL 36849.ORCID 0000-0002-9649-525X
Reza BehboudiAuburn University, Auburn, AL 36849.ORCID 0009-0009-2604-3854
Collin WardAuburn University, Auburn, AL 36849.
Minindu WeerakoonAuburn University, Auburn, AL 36849.ORCID 0009-0007-0237-2376
Sami KanaanFred Hutchison Cancer Center.ORCID 0000-0002-4608-0953
Skylar ReichleAuburn University, Auburn, AL 36849.
Nathan HunterAuburn University, Auburn, AL 36849.
Scott FurlanFred Hutchison Cancer Center.ORCID 0000-0003-3007-9840

Funding

A compass for those with relapsed leukemia after transplantR01CA289886 · NCI · FRED HUTCHINSON CANCER CENTER · PI Scott Nicholas Furlan · 2024 to 2026
$3.5M
NCI NIH HHS R01 CA289886
6 · The paper itself

Abstract

The existence of rare, genetically distinct cells can occur in various samples such as transplant patients, naturally occurring microchimerism between maternal and fetal tissues, and cancer samples with sufficient mutational burden. Computational methods for detecting these foreign cells are vital to studying these biological conditions. An application that is of particular interest is that of leukemia patients post hematopoietic cell transplant (HCT). In many leukemias, a primary therapy is HCT, after which, the primary genotype of the bone marrow and blood cells should be of donor origin. If cells exist that are of the patient's genotype and the cell type lineage of the particular leukemia, this is known as measurable residual disease (MRD). If the MRD is high enough, this may represent a relapse of the patient's leukemia. Furthermore, accurately estimating the MRD is important for driving clinical decision making for these patients. Here we present Cellector, a computational method for identifying rare foreign genotype cells in single cell RNAseq (scRNAseq) datasets. We show cellector accurately detects microchimeric cells down to an exceedingly low percentage of these cells present (0.05% or lower).

Identifiers

PMID41959341
PMCPMC13060372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.